Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Cis-trimethoxystilbene, exhibits higher genotoxic and antiproliferative effects than its isomer trans-trimethoxystilbene in MCF-7 and MCF-10A cell lines

Texto completo
Autor(es):
Goncalves, Natalia Dos Santos [1] ; Silva Pereira de Mello, Tamires Maria [1] ; Mizuno, Cassia Suemi [2] ; Haider, Saqlain [3] ; Dos Santos, Raquel Alves [1]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] Univ Franca, Lab Genet & Biol Mol, Av Dr Armando Salles de Oliveira 201, BR-14404600 Franca, SP - Brazil
[2] Univ New England, Westbrook Coll Hlth Profess, Sch Pharm, Dept Pharmaceut & Social Adm Sci, Portland, ME - USA
[3] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 - USA
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: GENETICS AND MOLECULAR BIOLOGY; v. 44, n. 3 2021.
Citações Web of Science: 0
Resumo

Abstract Stilbenes are a class of natural compounds with a wide variety of biological effects, such as antitumor activity. The best-known stilbene is resveratrol, whose clinical application is limited due to its low bioavailability. Methoxylated derivatives of this stilbene, including cis-trimethoxystilbene (cis-TMS) and trans-trimethoxystilbene (trans-TMS) have demonstrated more pronounced cytotoxic and anti-proliferative effects than resveratrol. Thus, the objective of this study is to evaluate and compare the cytotoxicity and antiproliferative effects of cis- and trans-TMS in MCF-7 and its normal counterpart MCF-10A. Both compounds were cytotoxic, genotoxic, and induced G2-M accumulation and cell death in the two cell lines. These results suggested that the genotoxicity of cis- and trans-TMS is involved in the reduction of cellular proliferation of MCF-7 and MCF-10A cells, but notably, such antiproliferative effects are more pronounced for cis- than trans-TMS. (AU)

Processo FAPESP: 18/16461-0 - Efeito do tratamento com cis-trimetoxiestilbeno após o silenciamento de TP53 por siRNA nas linhagens tumorais MCF-7 e MDA-MB-231: uma abordagem celular e molecular
Beneficiário:Raquel Alves dos Santos
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 14/12465-0 - Avaliação das vias de resposta a danos no DNA moduladas por estilbenos estruturalmente modificados
Beneficiário:Raquel Alves dos Santos
Modalidade de apoio: Auxílio à Pesquisa - Regular